The company reported that its deep neural network led to improved sensitivity and fewer unclassified findings. 

“The findings of this study highlight the need for strategies to reduce and manage the burden of false-positive ILR alerts,” the researchers said.

"These findings might imply that not all AFib is worth screening for, and not all screen-detected AFib merits anticoagulation," researchers wrote. 

This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.

Remote monitoring and high-tech health management solutions have dominated cardiology headlines for the better part of the past year, touted for their accessibility and preventive benefits. But that vision of remote monitoring as the future of CV care might be a skewed representation of our current reality.

Cardiologists discuss the questions and concerns swirling around the thriving wearables market as patients strap on a variety of smart devices and expect their physicians to catch up.

A remote monitoring protocol for heart failure patients with implantable electronic devices helped more of them stay out of the hospital over a one-year period than standard in-person visits, researchers reported at EHRA 2019.

A randomized trial published April 24 in JAMA suggests patients with lower-extremity peripheral artery disease (PAD) can’t be expected to improve walking performance on their own, even with the aid of wearable activity trackers and telephone coaching sessions.